Cambridge biotech startup grabs $65M to tackle liver disease By: Boston Business Journal via Business Journals June 25, 2018 at 07:00 AM EDT The company, Akero Therapeutics, is focused on a type of liver disease called NASH that affects an estimated 16 million Americans. Read More >>
